Manulife (Manufacturers Life Insurance)’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Buy |
19,029
+30
| +0.2% | +$226 | ﹤0.01% | 2673 |
|
|
2025
Q1 | $144K | Sell |
18,999
-5,826
| -23% | -$44.1K | ﹤0.01% | 2597 |
|
|
2024
Q4 | $302K | Sell |
24,825
-713
| -3% | -$8.68K | ﹤0.01% | 2448 |
|
|
2024
Q3 | $428K | Buy |
25,538
+10,363
| +68% | +$173K | ﹤0.01% | 2344 |
|
|
2024
Q2 | $265K | Buy |
15,175
+4,393
| +41% | +$76.6K | ﹤0.01% | 2476 |
|
|
2024
Q1 | $184K | Buy |
10,782
+90
| +0.8% | +$1.53K | ﹤0.01% | 2624 |
|
|
2023
Q4 | $109K | Hold |
10,692
| – | – | ﹤0.01% | 2792 |
|
|
2023
Q3 | $96.8K | Hold |
10,692
| – | – | ﹤0.01% | 2821 |
|
|
2023
Q2 | $115K | Sell |
10,692
-1,469
| -12% | -$15.8K | ﹤0.01% | 2803 |
|
|
2023
Q1 | $124K | Hold |
12,161
| – | – | ﹤0.01% | 2695 |
|
|
2022
Q4 | $128K | Buy |
12,161
+148
| +1% | +$1.56K | ﹤0.01% | 2727 |
|
|
2022
Q3 | $154K | Sell |
12,013
-314
| -3% | -$4.03K | ﹤0.01% | 2689 |
|
|
2022
Q2 | $158K | Buy |
12,327
+649
| +6% | +$8.32K | ﹤0.01% | 2768 |
|
|
2022
Q1 | $122K | Sell |
11,678
-2,634
| -18% | -$27.6K | ﹤0.01% | 2922 |
|
|
2021
Q4 | $221 | Buy |
14,312
+630
| +5% | +$10 | ﹤0.01% | 2838 |
|
|
2021
Q3 | $309K | Buy |
13,682
+5,805
| +74% | +$131K | ﹤0.01% | 2648 |
|
|
2021
Q2 | $203K | Buy |
7,877
+495
| +7% | +$12.8K | ﹤0.01% | 3093 |
|
|
2021
Q1 | $308K | Buy |
+7,382
| New | +$308K | ﹤0.01% | 2606 |
|